Bausch Health Companies | VRX - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Amgen USD 541M 0 2026-09
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 63.31M 4.36M 2026-06
Bausch Health Companies USD 374.25M 351K 2026-09
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 109.36M 1.44M 2026-09
Danaher USD 703.4M 500K 2026-09
Drreddys Laboratories INR 833.07M 382K 2026-09
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novo Nordisk DKK 4.43B 13.25M 2026-06
Pacira USD 39.9M 75K 2026-09
Perrigo USD 138.8M 700K 2026-09
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.37M 53K 2026-06
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
Vertex Pharmaceuticals USD 253.5M 200K 2026-09
Zoetis USD 407.49M 6.67M 2026-09